A detailed history of Kbc Group Nv transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Kbc Group Nv holds 1,531 shares of PRCT stock, worth $141,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,531
Previous 1,155 32.55%
Holding current value
$141,923
Previous $71,000 73.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$56.31 - $84.99 $21,172 - $31,956
376 Added 32.55%
1,531 $123,000
Q1 2024

May 08, 2024

BUY
$40.38 - $50.75 $46,638 - $58,616
1,155 New
1,155 $57,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.13B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.